Beihai Biotech
PrivateLast Round
Series C
Extension
Dec 12, 2023
Total Funding Raised
$42.99M
Company Overview
Beihai Biotech operates in Healthcare & Life Sciences and is based in Zhuhai. Its latest recorded funding round was a Series C Extension round in December 2023.
Beihai Biotech is a biopharmaceutical company that develops innovative oncology drugs to address unmet clinical needs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Beihai Biotech Comparables
Compare Beihai Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Conjupro Biotherapeutics, Inc. | 86% | |
| Sichuan Kelun Pharmaceutical Co Ltd | 81% | |
| CSPC Pharmaceutical Group Limited | 80% |
For institutional investors. Book with your work email.
Beihai Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Dec 12, 2023 | ||||
| Series B | Oct 31, 2022 | ||||
| Series A | Jan 6, 2022 | ||||
| Series A | Jul 1, 2021 | ||||
| Angel | Jan 1, 2017 |
For institutional investors. Book with your work email.
Beihai Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Oriza FOFs | Series B |
| Jinhang Group | Series B |
| Shenzhen Guozhong Venture Capital Management | Series B, Series A |
| GAINS Investment Corporation | Series C Extension |
| 珠海市人民政府国有资产监督管理委员会 | Series A |
| Yikai Venture Capital | Series A, Series B |
| Shenzhen Yifeng Investment Management Enterprise | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 12, 2023
GAINS Investment Corporation participated in the round.
- Oct 31, 2022
$27.39M round led by Yikai Venture Capital.
For institutional investors. Book with your work email.
Beihai Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Beihai Biotech's valuation, stock price, and market status.
Is Beihai Biotech a public or private company?
Beihai Biotech is a private company.
What is the current stock price of Beihai Biotech?
Beihai Biotech is a private company, so its shares have no public market price. Caplight tracks Beihai Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Beihai Biotech worth (valuation)?
Valuation information for Beihai Biotech is not publicly available.
Can I buy Beihai Biotech stock?
Beihai Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Beihai Biotech's last funding round?
Beihai Biotech's most recent funding round was Series C Extension on December 12, 2023.
Who are the main investors in Beihai Biotech?
Key investors in Beihai Biotech include Shenzhen Guozhong Venture Capital Management, Yikai Venture Capital.
Will Beihai Biotech IPO soon?
No public IPO plans have been announced for Beihai Biotech.
How can I track Beihai Biotech secondary market activity?
Caplight tracks bids, offers, and trades in Beihai Biotech's shares on secondary markets.